Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Is stereotactic radiotherapy a valid alternative to surgery for patients with stage I NSCLC?

Opportunities for immunotherapy in stage I NSCLC

Date

22 Oct 2023

Session

Is stereotactic radiotherapy a valid alternative to surgery for patients with stage I NSCLC?

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Silvia Novello

Authors

S. Novello

Author affiliations

  • Oncology Dept., Università Degli Studi Di Torino - Orbassano, 10043 - Orbassano/IT

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

A radiation oncologist’s perspective

Presenter: Matthias Guckenberger

Session: Is stereotactic radiotherapy a valid alternative to surgery for patients with stage I NSCLC?

Resources:

Slides

Webcast

A surgeon's perspective

Presenter: Gaetano Rocco

Session: Is stereotactic radiotherapy a valid alternative to surgery for patients with stage I NSCLC?

Resources:

Slides

Webcast

Discussion

Presenter: All Speakers

Session: Is stereotactic radiotherapy a valid alternative to surgery for patients with stage I NSCLC?

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.